{"id":3204,"date":"2022-10-15T18:31:42","date_gmt":"2022-10-15T18:31:42","guid":{"rendered":"https:\/\/demo.webtend.net\/wp\/oxence-light\/?p=3204"},"modified":"2025-02-06T09:14:09","modified_gmt":"2025-02-06T09:14:09","slug":"developing-the-nigeria-one-health-national-action-plan-on-antimicrobial-resistance-2-0","status":"publish","type":"post","link":"https:\/\/rbo.rw\/rcgb\/2022\/10\/15\/developing-the-nigeria-one-health-national-action-plan-on-antimicrobial-resistance-2-0\/","title":{"rendered":"Developing the Nigeria One Health National Action Plan on Antimicrobial Resistance (2.0)"},"content":{"rendered":"<h2 class=\"wp-block-heading\">Developing the Nigeria One Health National Action Plan on Antimicrobial Resistance (2.0)<\/h2><p class=\"wp-block-paragraph\">Since the launch of Nigeria\u2019s first National Action Plan (NAP 1.0), the country has made significant progress in mitigating antimicrobial resistance (AMR).\u00a0<a href=\"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance%22%20\/l%20%22:~:text=AMR%20is%20a%20natural%20process,in%20humans%2C%20animals%20and%20plants.\">Antimicrobial Resistance<\/a>\u00a0(AMR) occurs when antimicrobials become ineffective and lose their ability to kill or inhibit the growth of pathogens for which they were previously effective. This resistance makes antimicrobial medications, including antibiotics, ineffective and makes treating infections challenging or impossible. This raises the risk of disease spread, and results in serious illness, disability, and death.\u00a0\u00a0<\/p><p class=\"wp-block-paragraph\">Aware of the threat posed by AMR, the World Health Assembly (WHA) approved the&nbsp;<a href=\"https:\/\/www.who.int\/publications\/i\/item\/9789241509763\">Global Action Plan on Antimicrobial Resistance<\/a>&nbsp;(GAP) in 2015. Among its aims was the requirement that all Member States had national action plans (NAPs) that were in line with GAP\u2019s goals by 2017. Nigeria was 1 of the 100 countries that prepared a NAP by the end of March 2018.&nbsp;<a href=\"https:\/\/cdn.who.int\/media\/docs\/default-source\/a-future-for-children\/nigeria-amr-national-action-plan.pdf?sfvrsn=153f003d_1&amp;download=true\">Nigeria\u2019s first NAP<\/a>&nbsp;for AMR was a five-year plan (2017\u20132022) outlining goals drawn from examining the strengths, weaknesses, risks, and opportunities of the national AMR situation to mitigate the crisis.&nbsp;<\/p><p class=\"wp-block-paragraph\">Since the introduction of the NAP on AMR, Nigeria has made strides in addressing AMR in several arenas. For example, in education, AMR was introduced in core curricula in some pre-and in-service training and other continuing professional development for human health workers. Numerous Nigerian schools have adopted and implemented core curricula for undergraduate and graduate veterinarians as well as veterinary paraprofessionals to guarantee coverage of AMR and sensible antimicrobial usage in tertiary education and training programs as well.&nbsp;&nbsp;<\/p><p class=\"wp-block-paragraph\">The country\u2019s AMR status and the level of implementation had to be evaluated after the NAP expired in 2022, and the main conclusions from this assessment would be incorporated into the creation of the subsequent NAP. As a World Health Organization (WHO) Collaborating Centre, the One Health Trust (OHT) aided in conducting the evaluation (situational analysis) of Nigeria\u2019s NAP 1.0. The OHT Africa Team carried out the analysis with support from representatives of the Nigeria Centre for Disease Control, the Federal Ministry of Health, the Federal Ministry of Agriculture and Food Safety, the Federal Ministry of Environment, and the WHO Country Office.&nbsp;&nbsp;<\/p><p class=\"wp-block-paragraph\">Following completion of the situational analysis, a workshop on the development of the One Health National Action Plan on Antimicrobial Resistance (AMR NAP 2.0) was held in Abuja, the federal capital territory of Nigeria. The workshop attendees included important AMR stakeholders from the nation\u2019s animal, human, and environmental sectors. OHT was invited to provide input regarding the development of the new NAP, having played a major role in the preparation of the country\u2019s situational analysis document. I (<a href=\"https:\/\/onehealthtrust.org\/profile\/our-team\/oluwatosin-ajayi\/\">Oluwatosin Ajayi<\/a>, OHT Research Analyst) was privileged to represent the OHT team at the five-day workshop.&nbsp;&nbsp;<\/p><p class=\"wp-block-paragraph\"><img fetchpriority=\"high\" decoding=\"async\" src=\"https:\/\/onehealthtrust.org\/wp-content\/uploads\/2024\/02\/NAP-Blog-Figure-1-800x600.jpeg\" alt=\"OHT\u2019s Dr. Oluwatosin Ajayi at the workshop\" width=\"800\" height=\"600\"><\/p><p class=\"wp-block-paragraph\"><em>OHT\u2019s Dr. Oluwatosin Ajayi at the workshop<\/em><\/p><p class=\"wp-block-paragraph\">The workshop started with a meet and&nbsp;greet&nbsp;session on Tuesday, October 24,&nbsp;2023.&nbsp;I had a chance to get to know other participants from different sectors&nbsp;including&nbsp;academic researchers&nbsp;from tertiary institutions across&nbsp;the country;&nbsp;directors of&nbsp;pharmaceutical and&nbsp;medical institutes;&nbsp;founders of AMR-related non-governmental organizations; and&nbsp;representatives from the&nbsp;World Health Organization and World Organization for Animal Health.&nbsp;The NAP 2.0 workshop\u2019s goals were then discussed&nbsp;and there was a&nbsp;presentation outlining the NAP&nbsp;development&nbsp;process in other African nations.&nbsp;After that, the&nbsp;attendees were&nbsp;split up into five groups according to NAP priority areas.&nbsp;<\/p><p class=\"wp-block-paragraph\"><img decoding=\"async\" src=\"https:\/\/onehealthtrust.org\/wp-content\/uploads\/2024\/02\/NAP-Blog-Figure-2-800x600.jpeg\" alt=\"\" width=\"800\" height=\"600\"><\/p><p class=\"wp-block-paragraph\"><em>Some of the workshop participants<\/em><\/p><p class=\"wp-block-paragraph\">The NAP priority areas were awareness and knowledge of AMR; One Health surveillance on AMR and multidrug-resistant organisms; infection prevention and control, biosecurity, and WASH; antimicrobial stewardship programs; and research, development, and innovation. The fact that everyone was grouped based on their area of expertise made the tasks interesting. The infection prevention and control (IPC) team members, for example, stressed the need for vaccination and good hygiene in limiting exposure to harmful pathogens, which will lessen the need for antimicrobial usage and ultimately reduce the incidence of AMR. Being a Research analyst, I was in the Research group. At the end of day one, each group had to deliberate, review, and provide feedback on the strategic objectives for the NAP priorities.&nbsp;&nbsp;<\/p><p class=\"wp-block-paragraph\">The task for each group on the second and third days was to develop priority intervention and operational plans for their group. My group had to develop the operational plans for the research priority focus of the NAP. It was an interesting but challenging task, knowing the impact the exercise would have on Nigeria\u2019s health system. The research team consisted of professors from medical backgrounds, environmental health professionals, veterinarians, and biomedical researchers. Everyone expressed their thoughts, discussed their points of view, and contributed by drawing on their experience and expertise during the highly dynamic session.&nbsp;<\/p><p class=\"wp-block-paragraph\"><img decoding=\"async\" src=\"https:\/\/onehealthtrust.org\/wp-content\/uploads\/2024\/02\/NAP-Blog-Figure-3-800x600.jpeg\" alt=\"\" width=\"800\" height=\"600\"><\/p><p class=\"wp-block-paragraph\"><em>The research group during the development of the strategic and operational plans<\/em><\/p><p class=\"wp-block-paragraph\">The fourth and fifth days&nbsp;of the training were devoted to creating strategies for monitoring and evaluating the NAP operational plans.&nbsp;With&nbsp;all of&nbsp;the workshop&nbsp;objectives&nbsp;met by the end&nbsp;the fifth and last day, the Nigeria AMR Coordination Committee Chairperson expressed gratitude to all attendees for their hard work, dedication, and contributions to the creation of the&nbsp;new&nbsp;NAP.&nbsp;<\/p><p class=\"wp-block-paragraph\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/onehealthtrust.org\/wp-content\/uploads\/2024\/02\/NAP-Blog-Figure-4-800x600.jpeg\" alt=\"\" width=\"800\" height=\"600\"><\/p><p class=\"wp-block-paragraph\"><em>The research group during the development of the monitoring and evaluation plans<\/em><\/p><p class=\"wp-block-paragraph\"><strong>Source:<\/strong> <a href=\"https:\/\/onehealthtrust.org\/news-media\/blog\/developing-the-nigeria-one-health-national-action-plan-on-antimicrobial-resistance-2-0\/\">https:\/\/onehealthtrust.org\/news-media\/blog\/developing-the-nigeria-one-health-national-action-plan-on-antimicrobial-resistance-2-0\/<\/a><\/p><p class=\"wp-block-paragraph\"><\/p>","protected":false},"excerpt":{"rendered":"<p>Developing the Nigeria One Health National Action Plan on Antimicrobial Resistance (2.0) Since the launch of Nigeria\u2019s first National Action Plan (NAP 1.0), the country has made significant progress in mitigating antimicrobial resistance (AMR).\u00a0Antimicrobial Resistance\u00a0(AMR) occurs when antimicrobials become ineffective and lose their ability to kill or inhibit the growth of pathogens for which they [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":5225,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17],"tags":[30,31],"class_list":["post-3204","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-design","tag-relationship","tag-story"],"_links":{"self":[{"href":"https:\/\/rbo.rw\/rcgb\/wp-json\/wp\/v2\/posts\/3204","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rbo.rw\/rcgb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rbo.rw\/rcgb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rbo.rw\/rcgb\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rbo.rw\/rcgb\/wp-json\/wp\/v2\/comments?post=3204"}],"version-history":[{"count":2,"href":"https:\/\/rbo.rw\/rcgb\/wp-json\/wp\/v2\/posts\/3204\/revisions"}],"predecessor-version":[{"id":5227,"href":"https:\/\/rbo.rw\/rcgb\/wp-json\/wp\/v2\/posts\/3204\/revisions\/5227"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rbo.rw\/rcgb\/wp-json\/wp\/v2\/media\/5225"}],"wp:attachment":[{"href":"https:\/\/rbo.rw\/rcgb\/wp-json\/wp\/v2\/media?parent=3204"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rbo.rw\/rcgb\/wp-json\/wp\/v2\/categories?post=3204"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rbo.rw\/rcgb\/wp-json\/wp\/v2\/tags?post=3204"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}